How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?

被引：0
|
作者：
Matsuoka, T. [1 ,2 ,3 ]
Araki, M. [4 ]
Yamaguchi, H. [1 ]
Sato, W. [1 ]
Miyamoto, K. [5 ]
Kusunoki, S. [5 ]
Gold, R. [6 ]
Yamamura, T. [1 ,4 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Natl Inst Neurosci, Dept Immunol,Natl Ctr Neurol & Psychiat, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Tokyo, Japan
[3] Natl Ctr Neurol & Psychiat, Tokyo Metropolitan Inst Neurosci, Child Brain Project, Tokyo, Japan
[4] Natl Ctr Neurol & Psychiat, Natl Ctr Hosp, Multiple Sclerosis Ctr, Tokyo, Japan
[5] Kindai Univ, Dept Neurol, Fac Med, Osaka, Japan
[6] Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1755
引用
收藏
页码：1000 / 1001
页数：2
相关论文
共 50 条
  • [31] Long-term treatment of systemic onset juvenile idiopathic arthritis (SO-JIA) with humanized anti-IL-6 receptor monoclonal antibody, tocilizumab (Actemra®)
    Yokota, S
    Miyamae, T
    Kurosawa, R
    Ozawa, R
    Imagawa, T
    Mori, M
    Nishimoto, N
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S725 - S725
  • [32] Protective effects of anti-IL-6 antibody treatment in sepsis
    Neff, TA
    Riedemann, NC
    Guo, RF
    Laudes, I
    Sarma, V
    Ward, PA
    FASEB JOURNAL, 2002, 16 (04): : A592 - A592
  • [33] A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as monotherapy for patients with neuromyelitis optica spectrum disorder (NMOSD)
    Traboulsee, A.
    Greenberg, B.
    Bennett, J. L.
    Szczechowski, L.
    Fox, E.
    Shkrobot, S.
    Yamamura, T.
    Terada, Y.
    Kawata, Y.
    Melia, A.
    Gianella-Borradori, A.
    Weinshenker, B. G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 730 - 731
  • [34] Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
    Michot, J. -M.
    Albiges, L.
    Chaput, N.
    Saada, V.
    Pommeret, F.
    Griscelli, F.
    Balleyguier, C.
    Besse, B.
    Marabelle, A.
    Netzer, F.
    Merad, M.
    Robert, C.
    Barlesi, F.
    Gachot, B.
    Stoclin, A.
    ANNALS OF ONCOLOGY, 2020, 31 (07) : 961 - 964
  • [35] The Efficacy and Safety of the Anti-IL-6 Receptor Antibody Tocilizumab for Polymyalgia Rheumatica Patients with Resistance or Intolerance to Glucocorticoids and Methotrexate
    Hirata, Manami
    Ueno, Akiko
    Fujita, Kazuyuki
    Shibutou, Nobuyuki
    Yamamura, Masahiro
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [36] Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis
    Miyagawa, Ippei
    Nakayamada, Shingo
    Saito, Kazuyoshi
    Hanami, Kentaro
    Nawata, Masao
    Sawamukai, Norifumi
    Nakano, Kazuhisa
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2014, 24 (03) : 405 - 409
  • [37] CLAZAKIZUMAB Humanized Anti-IL-6 Monoclonal Antibody Treatment of Rheumatoid Arthritis Treatment of Autoimmune Diseases Oncolytic
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 633 - 636
  • [38] Anti-IL-6 monoclonal antibody (BE-8) and suramin for treatment of Castleman's disease (CD)
    Munshi, NC
    Wijdenes, J
    Fassas, A
    Vesole, D
    Jagannath, SJ
    Cheson, B
    Butch, A
    Dhodapkar, M
    Tricot, G
    Barlogie, B
    BLOOD, 1995, 86 (10) : 745 - 745
  • [39] Molecular mechanism of Anti-IL-6 receptor antibody treatment in collagen-induced arthritis
    Fuiimoto, Minoru
    Serada, Satoshi
    Matsukawa, Yuko
    Nakano, Mayumi
    Nishikawa, Teppei
    Kishimoto, Tadamitsu
    Naka, Tetsuji
    CYTOKINE, 2007, 39 (01) : 11 - 11
  • [40] Cytomegalovirus Reactivation Induced Acute Hepatitis and Gastric Erosions in a Patient with Rheumatoid Arthritis under Treatment with an Anti-IL-6 Receptor Antibody, Tocilizumab
    Komura, Takuya
    Ohta, Hajime
    Nakai, Ryotaro
    Seishima, Jun
    Yamato, Masatoshi
    Miyazawa, Masaki
    Kaji, Kiichiro
    Marukawa, Yohei
    Kagaya, Takashi
    Kitagawa, Kiyoki
    Kawashima, Atsuhiro
    Kaneko, Shuichi
    Unoura, Masashi
    INTERNAL MEDICINE, 2016, 55 (14) : 1923 - 1927
12345